The estrogen receptor coactivator AIB1 is a new putative prognostic biomarker in ER-positive/HER2-negative invasive lobular carcinoma of the breast.
Ulrik NarbeMartin SjöströmCarina ForsarePär-Ola BendahlSara AlknerL M Fredrik Leeb-LundbergKristina LövgrenLisa RydénChristian IngvarMårten FernöPublished in: Breast cancer research and treatment (2019)
AIB1 is a new putative prognostic biomarker in ER-positive/HER2-negative ILC.